Sign in
Taking people in United StatesNo phase

Tests ketogenic diet and ketone supplements in women with polycystic ovary syndrome

Compares a ketogenic diet with a ketone supplement in women with polycystic ovary syndrome.

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Registry title
Symptoms of Polycystic Ovarian Syndrome Ameliorated by Keto-Adaptation Pilot
Status
Recruiting
People taking part
40 people, planned
Starts
1 Dec 2026
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Ketogenic diet
  • Exogenous Ketone Supplement
Record updated
8 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18-40 with polycystic ovary syndrome (PCOS) to test two ketone-based approaches over 12 weeks.

Age
18-40 years
Sex
Women only
Disease stage
A clinical diagnosis of PCOS by Rotterdam criteria (at least two of: irregular or absent ovulation, signs of high male hormones, polycystic ovaries on ultrasound).
Earlier treatment
No hormonal contraception or medicines that change reproductive hormones in the 3 months before joining. Willing to keep current diet, exercise, medicine and supplement habits during the study.

Main reasons for not taking part

  • Already on a low-carbohydrate diet (<30% of total energy from carbohydrates)
  • Type 1 diabetes or uncontrolled type 2 diabetes
  • Weight loss of 10% or more of body weight in the last 6 months
  • Pregnant or breastfeeding
  • Active eating disorder or another condition that could interfere with the diet

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Female participants aged 18-40 years
  • Clinical diagnosis of Polycystic Ovary Syndrome (PCOS) according to Rotterdam criteria (presence of at least two of the following: oligo- or anovulation, clinical or biochemical signs of hyperandrogenism, and/or polycystic ovaries on ultrasound)
  • Willingness and ability to comply with all study procedures, including fasting (>10 hours; water only), avoidance of alcohol (>24 hours), and abstaining from exercise (>24 hours) prior to each test visit
  • Willing to maintain current diet, exercise, medication, and supplement habits throughout the study
  • Body mass index (BMI) ≥18 kg/m²
  • Access to a smartphone, computer, or tablet for digital tracking and study communication

Who cannot take part

  • Weight loss ≥10% of body weight within the previous 6 months
  • Use of hormonal contraception or medications known to alter reproductive hormones within 3 months prior to enrollment
  • Non-PCOS etiologies of anovulation (e.g., menopause, oophorectomy, or other reproductive disorders)
  • History of type 1 diabetes or uncontrolled type 2 diabetes
  • Active eating disorder or medical condition that could interfere with dietary intervention
  • Any condition that, in the opinion of the Investigator, could interfere with participation, data integrity, or safety
  • Current adherence to a low-carbohydrate diet (<30% of total energy from carbohydrates)
  • Pregnancy or breastfeeding

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

Where in United States

  • The Ohio State UniversityColumbus, United StatesContact: Madison KackleyTaking people

About the trial

What the trial wants to find out

The SPARK- Pilot study (Symptoms of PCOS Ameliorated by Responses to Keto-adaptation) is a 12-week clinical trial at The Ohio State University designed to explore how different ways of achieving ketosis may improve reproductive and metabolic health in women with Polycystic Ovary Syndrome (PCOS).

Read full original descriptionShow less

Participants will be randomly assigned to one of two groups:

* A ketogenic diet group, following a low-carbohydrate, nutrient-dense meal plan. * A mixed diet plus ketone supplement group, following general dietary guidelines while taking an exogenous ketone supplement.

The study will measure whether these approaches help restore regular ovulation and improve hormone balance, metabolism, and overall well-being. Optional imaging using MRI will also examine heart and ovarian health.

This pilot study will help researchers understand if ketogenic nutrition strategies are a safe, effective way to support menstrual regularity and reduce PCOS-related symptoms, providing groundwork for larger clinical trials.

The 2 groups in the trial

  • Ketogenic Diet (KD)Treatment being tested

    Participants in this arm will follow a well-formulated ketogenic diet designed to achieve and maintain nutritional ketosis (β-hydroxybutyrate ≥0.5 mmol/L). The diet will include non-starchy vegetables as the primary carbohydrate source (20-50 g/day), moderate protein (1.2-1.6 g/kg/day), and sufficient fat for energy and satiety. All meals and snacks will be provided for the first 2 weeks, followed by self-guided adherence with support from the study dietitian and educational resources. Daily fingerstick ketone and glucose levels will be monitored using KetoMojo.

    Treatment: Ketogenic diet

  • Mixed Diet + Exogenous Ketone SupplementExisting treatment, for comparison

    Participants in this arm will follow a balanced, mixed diet aligned with USDA macronutrient recommendations while consuming an exogenous ketone supplement throughout the 12-week intervention. The supplement is designed to raise circulating β-hydroxybutyrate to nutritional ketosis levels without carbohydrate restriction. As with the KD arm, all meals and snacks will be provided for the first 2 weeks, followed by self-guided adherence with ongoing dietitian support.

    Treatment: Exogenous Ketone Supplement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Symptoms of Polycystic Ovarian Syndrome Ameliorated by Keto-Adaptation Pilot
Plain-language title
Tests ketogenic diet and ketone supplements in women with polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07227363, who can take part
Record updated
8 May 2026